Literature DB >> 33855693

EUS-guided Anastomosis Complication in a Patient with Roux-en-Y Gastric Bypass: Dehiscence of the Surgical Anastomosis During Endoscopic Mucosal Resection Across EUS-guided Jejunum-gastric Anastomosis with Lumen Apposing Metal Stent.

Gianfranco Donatelli1, Fabrizio Cereatti2, Farida Daho3.   

Abstract

INTRODUCTION: Roux-en-Y gastric bypass (RYGB) is one of the most common surgical procedures for the management of morbid obesity. However, RYGB poses technical difficulties in exploring the gastric remnant and in performing endoscopic biliary interventions due to altered anatomy. Recently, EUS guided gastro-gastric anastomosis to access the excluded stomach has been introduced in order to allow direct trans-gastric interventions. METHOD AND MATERIAL: We report the case of a 38-year-old female referred to our unit to undergo EUS direct trans-gastric intervention (EDGI) for the management of a small stone in the biliary tract. Pre-procedural CT scan highlighted an abnormal distension of the gastric remnant. EUS guided jejuno-gastric anastomosis was carried out with the deployment of a 15 x 10 mm lumen apposing metal stent (LAMS).
RESULTS: After 3 days, an upper GI endoscopy was performed, highlighting a mobile 25 mm polyp near the pylorus. Therefore endoscopic resection was planned before the performance of the ERCP. Piecemeal endoscopic mucosectomy was carried out with no evidence of any adverse event. However, endoscopic evaluation after specimen retrieval detected an almost complete dehiscence of the anastomosis. Emergency surgery was decided with restoration of the continuity of the gastric cavity to allow future endoscopic examinations/procedures. DISCUSSION: Here, we report the first case of dehiscence of the surgical gastro-jejunal anastomosis during EDGI procedure. Performing an ERCP during EDGI is probably safer than performing gastric interventions. When performing EDGI, it is paramount to carefully evaluate the type of planned gastric procedure and to adopt a tailored approach according the several variables involved.

Entities:  

Keywords:  Altered anatomy; Axios; EDGI; EUS; Gastric By Pass; LAMS

Year:  2021        PMID: 33855693     DOI: 10.1007/s11695-021-05395-w

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  5 in total

1.  Temporary Trans-gastric Stent Deployment Over a 20 French Gastrostomy for Single-Stage Endoscopic Retrograde Cholangiopancreatography After Gastric Bypass.

Authors:  Gianfranco Donatelli; Fabrizio Cereatti; Andrea Spota; Thierry Tuszynski; David Danan; Jean-Loup Dumont
Journal:  Obes Surg       Date:  2020-07-13       Impact factor: 4.129

2.  Report of two cases of gastric cancer after bariatric surgery: lymphoma of the bypassed stomach after Roux-en-Y gastric bypass and gastrointestinal stromal tumor (GIST) after vertical banded gastroplasty.

Authors:  Arnaud de Roover; Olivier Detry; Laurence de Leval; Carla Coimbra; Claude Desaive; Pierre Honoré; Michel Meurisse
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

3.  Remnant Gastric Cancer After Roux-en-Y Gastric Bypass: Narrative Review of the Literature.

Authors:  Stefania Tornese; Alberto Aiolfi; Gianluca Bonitta; Emanuele Rausa; Guglielmo Guerrazzi; Piero Giovanni Bruni; Giancarlo Micheletto; Davide Bona
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

Review 4.  After you Roux, what do you do? A systematic review of most successful advanced assisted ERCP techniques in patients with various altered upper gastrointestinal surgical anatomical reconstructions with particular focus on RYGB (last 10 years).

Authors:  Mohamed Elsharif; Adam Gary Hague; Hussam Ahmed; Roger Ackroyd
Journal:  Clin J Gastroenterol       Date:  2020-08-18

5.  The EDGI new take on EDGE: EUS-directed transgastric intervention (EDGI), other than ERCP, for Roux-en-Y gastric bypass anatomy: a multicenter study.

Authors:  Matthew R Krafft; William Hsueh; Theodore W James; Thomas M Runge; Todd H Baron; Mouen A Khashab; Shayan S Irani; John Y Nasr
Journal:  Endosc Int Open       Date:  2019-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.